Filing Flows › Orthopediatrics (KIDS) › R&D spending
Orthopediatrics (KIDS) R&D spending by quarter
Orthopediatrics' R&D spending was $2.5M in Q3 2026 (third quarter 2026), +6% from Q2 2026. Over the last 7 quarters it ranged from $2.2M (Q2 2025) to $2.5M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.5M | +6% | +6% |
| Q2 2026 | $2.3M | +4% | +8% |
| Q1 2026 | $2.2M | -1% | -5% |
| Q4 2025 | $2.3M | -3% | — |
| Q3 2025 | $2.3M | +8% | — |
| Q2 2025 | $2.2M | -8% | — |
| Q1 2025 | $2.4M | — | — |
Q3 2026 at a glance
Orthopediatrics, Q3 2026: revenue $72.7M (+19% year over year), operating margin -5.8%, net loss $5.9M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Orthopediatrics' R&D spending?
Orthopediatrics' R&D spending was $2.5M in Q3 2026 (third quarter 2026), +6% from Q2 2026.
How has Orthopediatrics' R&D spending changed?
Over the last 7 quarters it ranged from $2.2M (Q2 2025) to $2.5M (Q3 2026).